Vaninder Dhillon/hopkinsmedicine.org
Feb 23, 2026, 16:49
Unpacking Genetic Markers for Thyroid Nodule Risks – Johns Hopkins Medicine
Johns Hopkins Medicine shared a post on LinkedIn։
“Is molecular testing in thyroid nodules helpful?
Dr. Vaninder Dhillon breaks down the latest debate from the AAO-HNSF 2025 meeting, exploring how genetic markers are reshaping risk assessment and treatment decisions.”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 13, 2026, 16:58Slavian Bumbu: A Low AMH Is Not an Infertility Diagnosis
-
Oct 13, 2026, 16:43Keshav Malhotra: No Embryologist or Laboratory Technique Can Guarantee Euploid Embryos
-
Oct 13, 2026, 16:37Tony Gordon: What Is the Most Successful Form of Fertility Treatment?
-
Oct 13, 2026, 16:29IVI RMA Global Introduces IVI Fertility
-
Oct 13, 2026, 16:12Devyanshi Dixit: PCOS May Be One Diagnosis, But Is It One Biological Disease?
-
Oct 13, 2026, 16:00Rajeev Agarwal: Age and Male Fertility, Through the PREPARE Method
-
Oct 13, 2026, 15:505 Years of the Patient Engagement Forum – HFEA
-
Oct 13, 2026, 15:41Cell-Free Fetal DNA Testing for Single-Gene Conditions – RCOG
-
Oct 13, 2026, 15:24Somil Singhal: Method for Enhancing Embryo Implantation Using Embryo Glue and Its Importance